In vitro antileishmanial activity of resveratrol originates from its cytotoxic potential against host cells

Planta Medica

Volumn 79, Issue 1, 2013, Pages 20-26

  Lucas, Inakatharina ^a   Kolodziej, Herbert ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

antileishmanial activity; cytotoxicity; Leishmania major GFP; macrophages; nitric oxide; resveratrol

Indexed keywords

AMPHOTERICIN B; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; RESVERATROL;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BONE MARROW CELL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HOST CELL; LEISHMANIA MAJOR; MACROPHAGE; MICROSCOPY; MOUSE; NONHUMAN; PROMASTIGOTE; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; CYTOTOXINS; FEMALE; LEISHMANIA MAJOR; MACROPHAGES; MICE; NITRIC OXIDE; STILBENES;

LEISHMANIA MAJOR;

EID: 84872083832     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1328020     Document Type: Article

References (30)

1. Maier W. A., Grunewald J., Habedank B., Hartelt K., Kampen H., Kimmig P., Naucke T., Oehme R., Vollmer A., Schöler A., Schmitt C. Possible effects of climatic changes on the distribution of arthropod (vector)-borne infectious diseases and human parasites in Germany. UFOPLAN 200 61 218/11. Climate Change: 2003; 05/03 (ISSN 1611-8855)
2. Balana-Fouce R., Reguera R. M., Cubria J. C., Ordonez D. The pharmacology of leishmaniasis. Gen Pharmacol: 1998; 30 435 443 (Pubitemid 28102818)
3. Akendengue B., Ngou-Milama E., Laurens A., Hocquemiller R. Recent advances in the fight against leishmaniasis with natural products. Parasite: 1999; 6 3 8 (Pubitemid 129560695)
4. Corona M. C., Croft S. L., Phillipson J. D. Natural products as sources of antiprotozoal drugs. Curr Opin Antiinfect Investig Drugs: 2000; 2 47 62 (Pubitemid 30128624)
5. Chan-Bacab M. J., Peña-Rodríguez L. M. Plant natural products with leishmanicidal activity. Nat Prod Rep: 2001; 18 674 688 (Pubitemid 34010018)
6. Kolodziej H., Kiderlen A. F. Antileishmanial activity and immune modulatory effects of tannins and related compounds on Leishmania parasitized RAW 264.7 cells. Phytochemistry: 2005; 66 2056 2071 (Pubitemid 41261917)
7. Kedzierski L., Sakthianandeswaren A., Curtis J. M., Andrews P. C., Junk P. C., Kedzierska K. Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr Med Chem: 2009; 16 599 614
8. Baur J. A., Sinclair D. A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev: 2006; 5 493 506 (Pubitemid 44136961)
9. Weng C. J., Wu C. F., Huang H. W., Wu C. H., Ho C. T., Yen G. C. Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells. J Agric Food Chem: 2010; 58 2886 2894
10. Turan B., Tuncay E., Vassort G. Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. J Bioenerg Biomembr: 2012; 44 281 296
11. Kim M. H., Yoo D. S., Lee S. Y. The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects. Pharmazie: 2011; 66 293 300
12. Kedzierski L., Curtis J. M., Kaminska M., Jodynis-Liebert J., Murias M. In vitro antileishmanial activity of resveratrol and its hydroxylated analogues against Leishmania major promastigotes and amastigotes. Parasitol Res: 2007; 120 91 97 (Pubitemid 47622187)
13. Kram D., Thäle C., Kolodziej H., Kiderlen A. F. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation. J Immunol Methods: 2008; 333 79 88
14. Ha D. S., Schwarz J. K., Turco S. J., Beverly S. M. Use of the green fluorescent protein as a marker in transfected Leishmania. Mol Biochem Parasitol: 1996; 77 57 64 (Pubitemid 26186162)
15. Berens L., Marr J. J. An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. J Parasitol: 1978; 64 160 (Pubitemid 8312837)
16. Kiderlen A. F., Kaye P. M. A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites. J Immunol Methods: 1990; 127 11 18 (Pubitemid 20066271)
17. Kedzierski L., Montgomery J., Bullen D., Curtis J. M., Gardiner E., Jimenez-Ruiz A., Handman E. A leucine-rich repeat motif of Leishmania parasite surface antigen 2 binds to macrophages through the complement receptor 3. J Immunol: 2004; 172 4902 4906 (Pubitemid 38456414)
18. Mosman T. J. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods: 1983; 65 55 63
19. Ding A. H., Nathan C. F., Stuehr D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol: 1988; 141 2407 2412
20. Green S. J., Melzer M. S., Hibbs J. B. Jr., Nacy C. A. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol: 1990; 144 278 283 (Pubitemid 20030489)
21. Lemesre J. L., Sereno D., Daulouède S., Veyret B., Brajon N., Vincendeau P. Leishmania spp.: nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote form. Exp Parasitol: 1997; 86 58 68 (Pubitemid 27224201)
22. Ma Z. H., Ma Q. Y., Wang L. C., Sha H. C., Wu S. L., Zhang M. Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflamm Res: 2005; 54 522 527 (Pubitemid 43042240)
23. Meng X. L., Yang J. Y., Chen G. L., Wang L. H., Zhang L. J., Wang S., Li J., Wu C. F. Effects of resveratrol and its derivatives on lipopolysaccharide- induced microglial activation and their structure-activity relationships. Chem Biol Interact: 2008; 174 51 59
24. Centeno-Baez C., Dallaire P., Marette A. Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1. Am J Physiol Endocrinol Metab: 2011; 301 E922 E930
25. Wang S., Qian Y., Gong D., Zhang Y., Fan Y. Resveratrol attenuates acute hypoxic injury in cardiomyocytes: correlation with inhibition of iNOS-NO signalling pathway. Eur J Pharm Sci: 2011; 44 416 421
26. Kim T., Suh E. S. Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy. Korean J Opthalmol: 2012; 24 108 118
27. Hattori R., Otani H., Maulik N., Das D. K. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol: 2002; 282 H1988 H1995 (Pubitemid 34663004)
28. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., Förstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation: 2002; 106 1652 1658
29. Vang O., Ahmad N., Baile C. A., Baur J. A., Brown K. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS ONE: 2011; 6 1 11
30. Bhat K. PL, Kosmeder J. W. II, Pezzuto J. M. Biological effects of resveratrol. Antioxid Redox Signal: 2001; 3 1041 1064 (Pubitemid 34027361)